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To the Editor—Thank you for the opportunity to
respond to the letter from Hope and Briggs regard-
ing the ISPOR Code of Ethics Task Force report
which was published in the March issue of 
 
Value in
Health
 
. Their letter raised nine points and, as chair
of the Task Force, I would like to approach this by
responding on a point-by-point basis. Because their
letter is being published in this same issue, I will
refrain from repeating each of their points in their
entirety in this letter.
1. The article does note that this was an effort to
build upon the work of the ISPOR Health Sci-
ence Policy Task Forces and to develop a code
of ethics that would be applicable to ISPOR
and its members. ISPOR is a society of a diverse
group of researchers, many of whom come
from disciplines such as economics, epidemiol-
ogy, public policy, health services research, clin-
ical research, and others. The Task Force never
intended to build a code of ethics for each dis-
cipline. Rather it intended to address the issues
broadly but with as much detail as practicable.
In this light, we believe that we have success-
fully accomplished our mission.
2. Our broader set of principles is set forth in the
form of identifying the various stakeholders
and how research issues affect them. The Task
Force spent considerable time and debate iden-
tifying these stakeholders and their issues, and
we believe that we have been most thorough.
Indeed the effort was hardly arbitrary, as Hope
and Briggs have suggested. Their letter does not
make clear why they believe the issues covered
in the Code are arbitrary.
3. ISPOR is a professional organization where
members share research and related informa-
tion. As such, it is not currently interested in
becoming a licensing or disciplinary organiza-
tion. The Code serves as a guide to its diverse
membership. One must raise the issue as to how
realistic any disciplinary process could be in an
organization with the membership and scope of
ISPOR. Hope and Briggs do not offer guidance
on this issue.
4. We did review the codes of ethics of other
organizations and, indeed, we did not note this
in the report. These were reviewed primarily for
their structural value and not their content.
Thus we did not deem it necessary, at the time,
to mention our review of them in our report.
5. The Task Force was formed by the ISPOR
Health Policy Committee. Each of the members
of the Task Force was asked to serve, and the
Task Force itself was not involved in selecting
its members. Having said that, we recognized
early on that we did not have representation
from outside the United States. Thus the Code
and the background report were sent out to at
least two European ISPOR members for their
review and comment. The Task Force subse-
quently incorporated their comments into its
work. The process of open review of the Code
was both lengthy and public. The Task Force
conducted two open meetings on the Code, one
in the United States at the Sixth Annual Meet-
ing in 2001 and the other at the Fourth Annual
European Congress in 2001. We did receive
comments from the membership at both of
these meetings and their comments were con-
sidered as we prepared our ﬁnal report. In addi-
tion, the Code and, later, a draft background
report were placed on ISPOR’s website for
more than 2 years and the membership was
asked to provide comments. Interestingly, we
did not receive even one comment from the
membership as a result of the web postings.
6. We do reference the Belmont Report in the Task
Force background paper. Indeed we deliber-
ately refrained from comparing this Code to
those of other organizations. In initial drafts we
made note of speciﬁc ethical problems around
the globe related to research and experimenta-
tion. Nevertheless, our outside reviewers sug-
gested that it would not be appropriate for us to
focus on the speciﬁc past problems of any par-
ticular country, and we felt that this was excel-
lent advice. The Code is certainly not meant to
replace any other code or guidelines. It is simply
meant to offer guidance to a somewhat diverse
population of researchers who have outcomes
research as a primary focus. Regarding guide-
lines for authorship, we regret that Hope and
Briggs believe that we suggest JAMA’s guide-
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lines be adopted by all outcomes researchers. In
our background report, we note that at least
one major peer-reviewed journal has adopted a
checklist for authorship determinations and we
cite JAMA in the references. We did not say, nor
did we intimate, that this was the only source.
Drs. Hope and Briggs also mentioned the issue
of denial of coverage. As far as this is con-
cerned, we felt that it goes far beyond a code of
ethics for researchers. The Task Force merely
raised this as a question and did not make any
recommendations on this issue. The Code basi-
cally says that researchers should do good,
transparent, and publishable research. This
work would then serve as a basis for those who
make decisions in the health-care arena. This is
a code of ethics for researchers, not for health-
care decision makers, and this is quite obvious
in the body of work that our Task Force has
produced. Thus, it is unclear as to why Hope
and Briggs have suggested that we go beyond
that. As far as the withholding of publication,
we cite another author’s point of view that it is
unethical to withhold publication. The Code,
itself, does not state this. Again, this is quite
clear from a reading of the Code and back-
ground paper. We recognized that withholding
of publication is a difﬁcult issue, especially in
light of contractual issues, and we felt that our
(and ISPOR’s) best contribution would be to
raise awareness. In the Code itself, we do state
that members should strive to publish their
work. To go beyond this would be impractical,
and when even one section of a Code of Ethics
is impractical, it could affect a reader’s judg-
ment of the entire Code.
7. Drs. Hope and Briggs, for some reason, have
focused on our use of the word “prudent.”
Their suggestion appears to go far beyond any
reasonable explanation of the context in which
we use the term so it is difﬁcult to respond to
this point.
8. In that same light, use of another term, in this
case “institutional review boards,” does not
control the entire code. Drs. Hope and Briggs
were aware of the fact that “research ethics
committee” means the same thing, and we
believe other ISPOR members will not be con-
fused over this. They do re-raise the issue of its
pointing to the fact that the Code is written
from a US perspective. Given our use of outside
reviewers from Europe and our two open meet-
ings, one in Europe, we disagree.
9. None of the Task Force reports were subjected
for peer review by the journal. These are not
research publications, but are reports of the
work of committees and should be viewed as
such.
We wish to thank Drs. Hope and Briggs for bring-
ing some of these issues before the readership and
we hope that we have adequately responded.—
Francis B. Palumbo, PhD, JD, on behalf of the Task
Force on Code of Ethics for Researchers: Francis
Palumbo, Rod Barnes, Patricia Deverka, William
McGhan, Lawrence Mullany, Albert Wertheimer.
